Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
VHH-His tag NanoAb™ Targeting Mouse 4-1BB, clone 2021
VHH-His tag NanoAb™ Targeting Mouse 4-1BB, clone 2021 (FITC)
VHH-His tag NanoAb™ Targeting Mouse ASGPR, clone 3133
VHH-His tag NanoAb™ Targeting Mouse ASGPR, clone 3133 (FITC)
VHH-His tag NanoAb™ Targeting Mouse CAIX, clone M121
VHH-His tag NanoAb™ Targeting Mouse CAIX, clone M121 (FITC)
VHH-His tag NanoAb™ Targeting Mouse CD138, clone 3123
VHH-His tag NanoAb™ Targeting Mouse CD19, clone 3107
VHH-His tag NanoAb™ Targeting Mouse CD19, clone 3107 (FITC)
VHH-His tag NanoAb™ Targeting Mouse CD276, clone 5013
VHH-His tag NanoAb™ Targeting Mouse CD276, clone 5013 (FITC)
VHH-His tag NanoAb™ Targeting Mouse CD38, clone 1122